An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. 2010

Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Properdin, a positive regulator of the alternative pathway (AP) of complement is important in innate immune defenses against invasive neisserial infections. Recently, commercially available unfractionated properdin was shown to bind to certain biological surfaces, including Neisseria gonorrhoeae, which facilitated C3 deposition. Unfractionated properdin contains aggregates or high-order oligomers, in addition to its physiological "native" (dimeric, trimeric, and tetrameric) forms. We examined the role of properdin in AP activation on diverse strains of Neisseria meningitidis and N. gonorrhoeae specifically using native versus unfractionated properdin. C3 deposition on Neisseria decreased markedly when properdin function was blocked using an anti-properdin mAb or when properdin was depleted from serum. Maximal AP-mediated C3 deposition on Neisseriae even at high (80%) serum concentrations required properdin. Consistent with prior observations, preincubation of bacteria with unfractionated properdin, followed by the addition of properdin-depleted serum resulted in higher C3 deposition than when bacteria were incubated with properdin-depleted serum alone. Unexpectedly, none of 10 Neisserial strains tested bound native properdin. Consistent with its inability to bind to Neisseriae, preincubating bacteria with native properdin followed by the addition of properdin-depleted serum did not cause detectable increases in C3 deposition. However, reconstituting properdin-depleted serum with native properdin a priori enhanced C3 deposition on all strains of Neisseria tested. In conclusion, the physiological forms of properdin do not bind directly to either N. meningitidis or N. gonorrhoeae but play a crucial role in augmenting AP-dependent C3 deposition on the bacteria through the "conventional" mechanism of stabilizing AP C3 convertases.

UI MeSH Term Description Entries
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D011414 Properdin A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections. Complement Factor P,Factor P, Complement
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001422 Bacterial Adhesion Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. Adhesion, Bacterial,Adhesions, Bacterial,Bacterial Adhesions
D051561 Complement C3 Convertase, Alternative Pathway A serine protease that is the complex of COMPLEMENT C3B and COMPLEMENT FACTOR BB. It cleaves multiple COMPLEMENT C3 into COMPLEMENT C3A (anaphylatoxin) and COMPLEMENT C3B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. Alternative Pathway C3 Convertase,C3 Convertase (C3bBb),C3 Convertase, Alternative Pathway,CVFBb,Complement 3 Convertase, Alternative Pathway,Complement 3b-Associated Factor B-fragment Bb,Complement C3 Convertase, CVFBb,Complement 3b Associated Factor B fragment Bb
D038381 Neisseria meningitidis, Serogroup A Strains of Neisseria meningitidis responsible for most outbreaks of meningococcal disease in Western Europe and the United States in the first half of the 20th century. They continue to be a major cause of disease in Asia and Africa, and especially localized epidemics in Sub-Sahara Africa. Meningococcus, Serogroup A,Meningococci, Serogroup A

Related Publications

Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
August 1987, Journal of clinical microbiology,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
February 2011, Expert review of anti-infective therapy,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
January 1987, Infection and immunity,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
February 2001, The Journal of antimicrobial chemotherapy,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
January 1976, Immunochemistry,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
January 2019, PeerJ,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
April 1984, Journal of clinical microbiology,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
April 1989, Clinical microbiology reviews,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
October 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Sarika Agarwal, and Viviana P Ferreira, and Claudio Cortes, and Michael K Pangburn, and Peter A Rice, and Sanjay Ram
May 1994, Infection and immunity,
Copied contents to your clipboard!